← Eichor
Condition: Primary Immune Deficiencies Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Primary Immune Deficiencies

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of Populations at Risk of Developing Chronic Hepatitis Linked to Chronic Enteric Virus Infection in Patients With
Phase N/A · 3 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06659588Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodefic
Phase 1/Phase 2 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT01306019Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00006150Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)
Phase 2 · 9 location(s) · New York Medical College · NCT03266640TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic D
Phase 2 · 1 location(s) · Johns Hopkins All Children's Hospital · NCT04414046Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)
Phase 1/Phase 2 · 7 location(s) · New York Medical College · NCT04197596Genetic Basis of Immunodeficiency
Phase N/A · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT00055172Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts
Phase 1 · 3 location(s) · Children's National Research Institute · NCT04691622Long-term Safety and Efficacy of Leniolisib in PIDs With Immune Dysregulation
Phase 2 · 4 location(s) · Pharming Technologies B.V. · NCT06990529Natural History of Sphingosine Phosphate Lyase Insufficiency Syndrome (SPLIS)
Phase N/A · 1 location(s) · University of California, San Francisco · NCT06669949STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Phase 3 · 51 location(s) · ADARx Pharmaceuticals, Inc. · NCT06960213Autologous Gene Therapy for Artemis-Deficient SCID
Phase 1/Phase 2 · 1 location(s) · University of California, San Francisco · NCT03538899Investigation of the Effects of Pulmonary Rehabilitation in Children With Primary Immunodeficiency
NA · 1 location(s) · Gazi University · NCT06092528Primitive Immunodeficiency, Intrauterine Devices and Menstrual Hygiene Products
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06519734Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant IR Capsule for On-Demand Treatment of Angioedema
Phase 3 · 32 location(s) · Pharvaris Netherlands B.V. · NCT07266805Pathogenic Study of Adult Immune Enteropathies
Phase N/A · 4 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT04280510Detection and Characterization of Neurologic Manifestations of Inborn and Acquired Errors of Immunity
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06169150Studies of Disorders With Increased Susceptibility to Fungal Infections
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT01222741Registry of Older Patients With Cancer
Phase N/A · 7 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT01137825Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation
Phase N/A · 1 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT04902807The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Tr
Phase 2 · 1 location(s) · Mayo Clinic · NCT07285044EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection
Phase 2 · 8 location(s) · New York Medical College · NCT03266653Detection and Characterization of Infections and Infection Susceptibility
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00404560Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death
Phase N/A · 7 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00246857Exercise Intervention and Immunodeficiency
NA · 2 location(s) · Yale University · NCT07698197Study of Chediak-Higashi Syndrome
Phase N/A · 1 location(s) · National Human Genome Research Institute (NHGRI) · NCT00005917The Experience of Screening for SCID
Phase N/A · 1 location(s) · King's College London · NCT05651113Study of BP-SCIG 20% in Patients With Primary Immunodeficiency (PID)
Phase 3 · 12 location(s) · Biopharma Plasma LLC · NCT07346859Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in
Phase 3 · 62 location(s) · Pharvaris Netherlands B.V. · NCT06679881Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifest
Phase 2 · 1 location(s) · Paul Szabolcs · NCT07284641
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.